全文获取类型
收费全文 | 89939篇 |
免费 | 9571篇 |
国内免费 | 6704篇 |
专业分类
耳鼻咽喉 | 722篇 |
儿科学 | 1230篇 |
妇产科学 | 906篇 |
基础医学 | 8709篇 |
口腔科学 | 1660篇 |
临床医学 | 12025篇 |
内科学 | 11339篇 |
皮肤病学 | 804篇 |
神经病学 | 3805篇 |
特种医学 | 3259篇 |
外国民族医学 | 35篇 |
外科学 | 7903篇 |
综合类 | 20205篇 |
现状与发展 | 33篇 |
一般理论 | 2篇 |
预防医学 | 7498篇 |
眼科学 | 2127篇 |
药学 | 10205篇 |
115篇 | |
中国医学 | 6868篇 |
肿瘤学 | 6764篇 |
出版年
2024年 | 267篇 |
2023年 | 1369篇 |
2022年 | 2901篇 |
2021年 | 4666篇 |
2020年 | 3658篇 |
2019年 | 2894篇 |
2018年 | 2944篇 |
2017年 | 3055篇 |
2016年 | 2737篇 |
2015年 | 4236篇 |
2014年 | 5124篇 |
2013年 | 5091篇 |
2012年 | 7472篇 |
2011年 | 8001篇 |
2010年 | 5976篇 |
2009年 | 5075篇 |
2008年 | 5530篇 |
2007年 | 5309篇 |
2006年 | 4998篇 |
2005年 | 4277篇 |
2004年 | 3432篇 |
2003年 | 3303篇 |
2002年 | 2861篇 |
2001年 | 2285篇 |
2000年 | 1811篇 |
1999年 | 1471篇 |
1998年 | 866篇 |
1997年 | 847篇 |
1996年 | 679篇 |
1995年 | 627篇 |
1994年 | 497篇 |
1993年 | 290篇 |
1992年 | 331篇 |
1991年 | 284篇 |
1990年 | 210篇 |
1989年 | 187篇 |
1988年 | 184篇 |
1987年 | 132篇 |
1986年 | 100篇 |
1985年 | 74篇 |
1984年 | 36篇 |
1983年 | 30篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 8篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1972年 | 3篇 |
1970年 | 4篇 |
1966年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
21.
23.
24.
25.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
26.
2017年12月至2018年12月,在天津医科大学总医院健康管理中心定期健康体检的3 509名研究对象中,曾罹患肿瘤、罹患慢病和健康对照三组分别有399、1 555、1 555名。年龄为(55.87±11.98)岁,男性占31.38%。慢病组MS患病率(42.44%)高于曾罹患肿瘤组(34.59%)和健康对照组(18.65%)( P<0.001)。与健康对照组相比,曾罹患肿瘤组和慢病组MS患病风险 OR(95% CI)值分别为2.13(1.61~2.83)和2.85(2.23~3.66);曾罹患乳腺癌和甲状腺癌MS患病风险 OR(95% CI)值分别为3.56(2.04~6.21)和2.77(1.46~5.25)。 相似文献
27.
The serrated pathway (SP) can be viewed as two parallel, but partially overlapping, arrays of colorectal precursor lesions, and their respective endpoint carcinomas, that are distinct from those of the conventional adenoma–carcinoma sequence (APC‐pathway). In this review we focus at the outset on the clinical impact, pathological features, molecular genetics and biological behaviours of the various SP cancers. Then we summarize the clinicopathological features, classification and molecular profiles of the two main precursor lesions that anchor the respective pathways: (i) sessile serrated adenoma/polyp (SSA/P), also called sessile serrated lesion (SSL), and (ii) traditional serrated adenoma (TSA). Activating mutations of the RAS–RAF–MAPK pathway initiate and sustain the lesions of the SP, and CpG island methylation of the promoter regions of tumour suppressor and DNA repair genes play the major role in their neoplastic progression. The SP includes microsatellite stable (MSS) carcinomas that are among the most biologically aggressive colorectal carcinomas (CRC), and also accounts for the great preponderance of sporadic hypermutated, mismatch repair (MMR)‐deficient or microsatellite instable (MSI) CRC. The identification, removal and appropriate classification of at‐risk SP precursors and surveillance of individuals who harbour these lesions present a challenge and opportunity for CRC prevention and mortality reduction. 相似文献
28.
目的 通过对公开发表在网络和数据库的有关中医药治疗2019新型冠状病毒肺炎(corona virus disease 2019,COVID-19)的文献进行方、药、证的可视化分析,客观全面的对COVID-19的中医药治疗进行探讨,为现代中医临床诊疗提供参考。方法 本文选用运用文献计量学方法和VOSviewer可视化软件对纳入文献中的用药情况进行数据拆分、整理和分析。结果 本研究高质量数据的主要期刊来源是核心期刊《中医杂志》;新冠临床用方以解表清热剂、开窍补益剂、辟秽祛湿剂为主;临床用药以解表药、清热解毒药、化湿祛痰药以及补益药为主;临床治病思路以六经辨证、三焦辨证和卫气营血辨证理论为指导;临床常见证型为湿、热、寒、毒相关证型;重视新冠前期预防以及后期恢复调养;治疗过程用药考究,注重养阴与祛邪并进。结论 新冠的中医临床诊治考病全面,并注重养阴与祛邪并进,可为官方制定治疗方案提供参考。 相似文献
29.
30.